Search

everythinglearnresearchcommunity

for

Search:↓

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

Trichobiolight effectively treats hair loss with 82.5% success.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Panax ginseng might help with hair growth and has fewer side effects than synthetic treatments.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Antioxidants can help improve hair growth in people with alopecia areata.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Higher sebum levels are linked to more severe male baldness.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Epinephrine does not significantly affect the severity of hair loss after surgery.

The document concludes that scalp conditions have various causes and can present in many different ways.

The model and estimator can predict drug exposure in kidney transplant patients well.

Topical tacrolimus is effective and safe for treating alopecia areata.

Platelet-rich plasma injections are an effective treatment for hair loss with minimal side effects.

The document covers various dermatological treatments and conditions.